Marine Drugs (Oct 2018)

Anthracimycin B, a Potent Antibiotic against Gram-Positive Bacteria Isolated from Cultures of the Deep-Sea Actinomycete <i>Streptomyces cyaneofuscatus</i> M-169

  • Víctor Rodríguez,
  • Jesús Martín,
  • Aida Sarmiento-Vizcaíno,
  • Mercedes de la Cruz,
  • Luis A. García,
  • Gloria Blanco,
  • Fernando Reyes

DOI
https://doi.org/10.3390/md16110406
Journal volume & issue
Vol. 16, no. 11
p. 406

Abstract

Read online

The potent antimicrobial extract of a culture of the marine derived actinomycete Streptomyces cyaneofuscatus M-169 was fractionated by reversed phase flash chromatography and preparative HPLC to yield the new Gram-positive antibiotic, anthracimycin B (1), together with its congener, anthracimycin (2). The structure of the new compound was established by analysis of its ESI-TOF MS and 1D and 2D NMR spectra, and comparison with data published for anthracimycin and anthracimycin BII-2619 (3). Notably, anthracimycin seemed to be the major and almost unique component of the extract detected by HPLC-UV-MS, making our S. cyanofuscatus strain an excellent candidate for further biosynthetic studies of this potent antibiotic.

Keywords